• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCL12 诱导的趋化作用在 ZAP-70 阴性慢性淋巴细胞白血病患者的 T 细胞中受损。

CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.

机构信息

Laboratorio de Inmunología Oncológica, IIHema, Academia Nacional de Medicina, Buneos Aires, Argentina.

出版信息

Haematologica. 2010 May;95(5):768-75. doi: 10.3324/haematol.2009.013995. Epub 2010 Feb 9.

DOI:10.3324/haematol.2009.013995
PMID:20145264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2864383/
Abstract

BACKGROUND

T cells from patients with chronic lymphocytic leukemia may play an important role in contributing to the onset, sustenance, and exacerbation of the disease by providing survival and proliferative signals to the leukemic clone within lymph nodes and bone marrow.

DESIGN AND METHODS

By performing chemotaxis assays towards CXCL12, CCL21 and CCL19, we sought to evaluate the migratory potential of T cells from chronic lymphocytic leukemia patients. We next analyzed the chemokine-induced migration of T cells, dividing the chronic lymphocytic leukemia samples according to their expression of the poor prognostic factors CD38 and ZAP-70 in leukemic cells determined by flow cytometry.

RESULTS

We found that T cells from patients with chronic lymphocytic leukemia are less responsive to CXCL12, CCL21 and CCL19 than T cells from healthy adults despite similar CXCR4 and CCR7 expression. Following separation of the patients into two groups according to ZAP-70 expression, we found that T cells from ZAP-70-negative samples showed significantly less migration towards CXCL12 compared to T cells from ZAP-70-positive samples and that this was not due to defective CXCR4 down-regulation, F-actin polymerization or to a lesser expression of ZAP-70, CD3, CD45, CD38 or CXCR7 on these cells. Interestingly, we found that leukemic cells from ZAP-70-negative samples seem to be responsible for the defective CXCR4 migratory response observed in their T cells.

CONCLUSIONS

Impaired migration towards CXCL12 may reduce the access of T cells from ZAP-70-negative patients to lymphoid organs, creating a less favorable microenvironment for leukemic cell survival and proliferation.

摘要

背景

慢性淋巴细胞白血病患者的 T 细胞可能通过向淋巴结和骨髓中的白血病克隆提供生存和增殖信号,在疾病的发生、维持和恶化中发挥重要作用。

设计与方法

通过对 CXCL12、CCL21 和 CCL19 的趋化作用分析,我们评估了慢性淋巴细胞白血病患者 T 细胞的迁移潜能。接下来,我们根据流式细胞术检测到的白血病细胞中 CD38 和 ZAP-70 这两个预后不良因素的表达,分析了趋化因子诱导的 T 细胞迁移。

结果

尽管慢性淋巴细胞白血病患者和健康成年人的 T 细胞表达相似水平的 CXCR4 和 CCR7,但前者对 CXCL12、CCL21 和 CCL19 的反应性明显低于后者。根据 ZAP-70 的表达将患者分为两组后,我们发现 ZAP-70 阴性样本的 T 细胞向 CXCL12 的迁移明显少于 ZAP-70 阳性样本的 T 细胞,而且这并非由于 CXCR4 下调缺陷、F-肌动蛋白聚合或这些细胞上 ZAP-70、CD3、CD45、CD38 或 CXCR7 的表达较少所致。有趣的是,我们发现 ZAP-70 阴性样本的白血病细胞似乎负责其 T 细胞中观察到的 CXCR4 迁移反应缺陷。

结论

向 CXCL12 的迁移受损可能会减少 ZAP-70 阴性患者 T 细胞进入淋巴器官的机会,为白血病细胞的生存和增殖创造一个不利的微环境。

相似文献

1
CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.CXCL12 诱导的趋化作用在 ZAP-70 阴性慢性淋巴细胞白血病患者的 T 细胞中受损。
Haematologica. 2010 May;95(5):768-75. doi: 10.3324/haematol.2009.013995. Epub 2010 Feb 9.
2
ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL).ZAP-70的表达与B细胞慢性淋巴细胞白血病(B-CLL)中对迁移和生存信号作出反应的能力增强相关。
Blood. 2006 May 1;107(9):3584-92. doi: 10.1182/blood-2005-04-1718. Epub 2005 Dec 6.
3
Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib.慢性淋巴细胞白血病细胞在 CXCL12 的刺激下接受 RAF 依赖性的生存信号,而这些信号对索拉非尼的抑制作用敏感。
Blood. 2011 Jan 20;117(3):882-9. doi: 10.1182/blood-2010-04-282400. Epub 2010 Nov 15.
4
Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration.通过ZAP-70发出信号是CXCL12介导的T细胞跨内皮迁移所必需的。
Blood. 2002 May 1;99(9):3111-8. doi: 10.1182/blood.v99.9.3111.
5
Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.慢性淋巴细胞白血病细胞中的克隆异质性:CD38、ZAP-70阳性细胞对表面IgM交联的反应更佳
Haematologica. 2008 Mar;93(3):413-22. doi: 10.3324/haematol.11646. Epub 2008 Feb 20.
6
CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients.趋化因子 CXCL12 是慢性淋巴细胞白血病患者 CD4+ T 细胞激活和增殖的共刺激因子。
Cancer Immunol Immunother. 2013 Jan;62(1):113-24. doi: 10.1007/s00262-012-1320-7. Epub 2012 Jul 29.
7
ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation.ZAP-70 通过 IgM-ERK1/2 的激活诱导 CCR7 的表达,从而增强恶性 B 淋巴细胞向 CCL21 的迁移。
Blood. 2011 Oct 20;118(16):4401-10. doi: 10.1182/blood-2011-01-333682. Epub 2011 Aug 24.
8
Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45.膜酪氨酸磷酸酶CD45对CXCR4介导的T细胞趋化性和丝裂原活化蛋白激酶激活的差异调节
J Biol Chem. 2003 Mar 14;278(11):9536-43. doi: 10.1074/jbc.M211803200. Epub 2003 Jan 8.
9
Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).B细胞慢性淋巴细胞白血病的骨髓浸润模式与免疫球蛋白重链可变区突变状态及70-kd ζ相关蛋白(ZAP-70)的表达有关。
Hum Pathol. 2006 Sep;37(9):1153-61. doi: 10.1016/j.humpath.2006.04.016. Epub 2006 Jul 7.
10
Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.使用优化的流式细胞术方法对B细胞慢性淋巴细胞白血病患者ZAP-70表达的多中心研究。
Haematologica. 2008 Feb;93(2):215-23. doi: 10.3324/haematol.11622. Epub 2008 Jan 26.

引用本文的文献

1
Ibrutinib Does Not Impact CCR7-Mediated Homeostatic Migration in T-Cells from Chronic Lymphocytic Leukemia Patients.依鲁替尼不影响慢性淋巴细胞白血病患者T细胞中CCR7介导的稳态迁移。
Cancers (Basel). 2022 May 31;14(11):2729. doi: 10.3390/cancers14112729.
2
Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.关于淋巴结和 CLL 细胞:解析 CCR7 在 CLL 发病机制中的作用及其作为治疗靶点的潜力。
Front Immunol. 2021 Mar 24;12:662866. doi: 10.3389/fimmu.2021.662866. eCollection 2021.
3
Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia: New Insights into Leukemic Progression.慢性淋巴细胞白血病中的脂蛋白脂肪酶表达:白血病进展的新见解。
Molecules. 2017 Dec 5;22(12):2083. doi: 10.3390/molecules22122083.
4
The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.激酶抑制剂R406和GS-9973损害慢性淋巴细胞白血病患者的T细胞功能以及利妥昔单抗的巨噬细胞介导的抗肿瘤活性。
Cancer Immunol Immunother. 2017 Apr;66(4):461-473. doi: 10.1007/s00262-016-1946-y. Epub 2016 Dec 23.
5
Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide.慢性淋巴细胞白血病细胞通过改变 Rho GTPase 信号转导诱导 LFA-1 定向 T 细胞运动缺陷,而来那度胺可使其逆转。
Blood. 2013 Apr 4;121(14):2704-14. doi: 10.1182/blood-2012-08-448332. Epub 2013 Jan 16.
6
CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients.趋化因子 CXCL12 是慢性淋巴细胞白血病患者 CD4+ T 细胞激活和增殖的共刺激因子。
Cancer Immunol Immunother. 2013 Jan;62(1):113-24. doi: 10.1007/s00262-012-1320-7. Epub 2012 Jul 29.
7
The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells.阿普利啶在慢性淋巴细胞白血病(CLL)中的细胞毒性活性是通过直接作用于白血病细胞和间接作用于单核细胞衍生细胞来介导的。
Invest New Drugs. 2012 Oct;30(5):1830-40. doi: 10.1007/s10637-011-9740-3. Epub 2011 Sep 2.
8
From prostate to bone: key players in prostate cancer bone metastasis.从前列腺到骨骼:前列腺癌骨转移的关键因素。
Cancers (Basel). 2011;3(1):478-93. doi: 10.3390/cancers3010478.

本文引用的文献

1
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.CD38/CD31、CCL3和CCL4趋化因子以及CD49d/血管细胞黏附分子-1通过维持慢性淋巴细胞白血病细胞存活的一系列连续事件相互关联。
Cancer Res. 2009 May 1;69(9):4001-9. doi: 10.1158/0008-5472.CAN-08-4173. Epub 2009 Apr 21.
2
High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.慢性淋巴细胞白血病B细胞在类滋养细胞共培养中以及BCR刺激后对T细胞趋化因子CCL3和CCL4的高水平表达。
Blood. 2009 Mar 26;113(13):3050-8. doi: 10.1182/blood-2008-07-170415. Epub 2008 Dec 12.
3
Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukaemia.ZAP-70+/CD38+ 慢性淋巴细胞白血病患者 T 细胞中的端粒显著缩短。
Br J Haematol. 2008 Nov;143(3):383-6. doi: 10.1111/j.1365-2141.2008.07363.x. Epub 2008 Aug 28.
4
Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?慢性淋巴细胞白血病的新见解:我们是否更接近了解该疾病的发病机制?
J Clin Oncol. 2008 Sep 20;26(27):4497-503. doi: 10.1200/JCO.2007.15.4393. Epub 2008 Jul 28.
5
Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug.慢性淋巴细胞白血病T细胞表现出免疫突触形成受损,而这可以通过一种免疫调节药物逆转。
J Clin Invest. 2008 Jul;118(7):2427-37. doi: 10.1172/JCI35017.
6
Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.趋化因子受体CXCR5及其配体CXCL13在B细胞慢性淋巴细胞白血病中的过表达
Blood. 2007 Nov 1;110(9):3316-25. doi: 10.1182/blood-2007-05-089409. Epub 2007 Jul 25.
7
Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.ZAP-70与CD38联合分析在慢性淋巴细胞白血病中的预后意义
Am J Hematol. 2007 Sep;82(9):787-91. doi: 10.1002/ajh.20936.
8
T-cell abnormalities in patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者的T细胞异常
Leuk Lymphoma. 2006 Jul;47(7):1197-8. doi: 10.1080/10428190600687976.
9
CXCR4 physically associates with the T cell receptor to signal in T cells.CXCR4与T细胞受体在物理上相互作用,从而在T细胞中发出信号。
Immunity. 2006 Aug;25(2):213-24. doi: 10.1016/j.immuni.2006.06.015.
10
In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.基础科学与临床研究的协同洞察:CD38作为慢性淋巴细胞白血病发病机制网络的标志物和关键组成部分。
Blood. 2006 Aug 15;108(4):1135-44. doi: 10.1182/blood-2006-01-013003. Epub 2006 Apr 18.